Browse hierarchy: [Ophthalmic (OP)](/submissions/OP) → [Subpart F — Therapeutic Devices](/submissions/OP/subpart-f%E2%80%94therapeutic-devices) → [21 CFR 886.5000](/submissions/OP/subpart-f%E2%80%94therapeutic-devices/886.5000) → QQJ — Applicator, Negative Pressure, External, Ocular

# QQJ · Applicator, Negative Pressure, External, Ocular

_Ophthalmic · 21 CFR 886.5000 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/QQJ

## Overview

- **Product Code:** QQJ
- **Device Name:** Applicator, Negative Pressure, External, Ocular
- **Regulation:** [21 CFR 886.5000](/submissions/OP/subpart-f%E2%80%94therapeutic-devices/886.5000)
- **Device Class:** 2
- **Review Panel:** [Ophthalmic](/submissions/OP)

## Identification

External ocular negative pressure system. An external ocular negative pressure system uses hardware and software to create negative pressure in front of the eye to temporarily lower intraocular pressure in glaucoma patients. The FSYX Ocular Pressure Adjusting Pump System is indicated for the reduction of Intraocular Pressure (IOP) during sleep in adult patients with open-angle glaucoma and IOP ≤ 21 mmHg who are currently using or have undergone another IOP-lowering treatment.

## Classification Rationale

CLASSIFICATION: II. The device is subject to general controls and special controls as defined in 21 CFR 886.5000.

## Special Controls

In combination with the general controls of the FD&C Act. the external ocular negative pressure system is subject to the following special controls:

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN230055](https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/QQJ/DEN230055.md) | FSYX™ Ocular Pressure Adjusting Pump (FSYX™ OPAP) System | Balance Ophthalmics, Inc. | Jun 27, 2024 | DENG |

## Top Applicants

- Balance Ophthalmics, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/QQJ](https://fda.innolitics.com/submissions/OP/subpart-f%E2%80%94therapeutic-devices/QQJ)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com